HPL · Hoechst Pakistan Limited
Hoechst Pakistan Reports 9M 2026 Financial Results and Commercial Partnership
Official PSX filing title: FINANCIAL RESULTS FOR THE NINE MONTHS AND QUARTER ENDED SEPTEMBER 30, 2026
- Filed
- 21 October 2026 at 3:13 pm
- Category
- Financials
- Sentiment
- Good
- Impact
- High
Executive summary
Hoechst Pakistan Limited reported its financial results for the nine months and quarter ended September 30, 2026, showing growth in net profit compared to the same period last year. Additionally, the company disclosed a commercial partnership with Switzerland-based Tentan AG to distribute the medical device 'Dianatal Obstetric Gel' in Pakistan, with commercialization expected in the first half of 2027.
Key takeaways
- Consolidated profit after tax for the nine months ended September 30, 2026 rose to PKR 2,807,289 thousand compared to PKR 2,210,646 thousand in the comparative period.
- Consolidated earnings per share (EPS) for the nine months increased to PKR 291.07 from PKR 229.21.
- Consolidated revenue from contracts with customers for the nine months stood at PKR 24,525,366 thousand.
- The board did not recommend any cash dividend, bonus shares, or right shares for the period.
- The company secured regulatory approvals for the exclusive distribution of Tentan AG's 'Dianatal Obstetric Gel' in Pakistan, targeting product commercialization in the first half of 2027.
Filing details
Financial results
Quarterly · Unaudited · Consolidated · 30 September 2026
Figures in PKR '000
Reporting period
Nine Months Ended
- Income
- 24,525,366 (prior 24,582,840)
- Profit after tax
- 2,807,289 (prior 2,210,646)
- EPS
- 291.07 (prior 229.21)
Quarter
Quarter Ended
- Income
- 7,821,093 (prior 8,289,279)
- Profit after tax
- 615,989 (prior 867,612)
- EPS
- 63.87 (prior 89.96)
- Obtained all applicable legal and regulatory approvals for the distribution of medical device Dianatal Obstetric Gel of Tentan AG within Pakistan under an exclusive distribution agreement, with commercialization expected during the first half of 2027.
Dividend and entitlement
- Type
- None
- Notes
- The filing explicitly states NIL cash dividend, NIL bonus shares, and NIL right shares.
- #financial-results
- #earnings
- #dividend
- #expansion
- #pharmaceuticals
Please cross-check with the official PSX filing before making an investment decision.